Company profile: TriSalus
1.1 - Company Overview
Company description
- Provider of novel infusion systems for the interventional radiology market, including Pressure-Enabled Drug Delivery to overcome intratumoral pressure and enhance local drug concentrations; an integrated platform combining immunomodulation therapy with proprietary intravascular regional delivery for liver and pancreatic tumors; and investigational TLR9 agonist nelitolimod (SD-101), evaluated in ongoing PERIO-01 and PERIO-02 clinical trials.
Products and services
- Integrated Therapeutic Platform: A platform combining immunomodulation therapy with proprietary intravascular regional delivery to address barriers in treating liver and pancreatic tumors
- Pressure-Enabled Drug Delivery (PEDD): A pressure-modulated method engineered to overcome intratumoral pressure by controlling pressure and flow, enhancing local drug concentrations within tumors
- Nelitolimod (SD-101): An investigational TLR9 agonist that reactivates immune responses within the liver and pancreas to enable deeper, more durable responses to other immunotherapeutics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TriSalus
Cellectar Biosciences
HQ: United States
Website
- Description: Provider of radiopharmaceutical cancer therapies and diagnostics, designing phospholipid drug conjugates that target tumor cells to detect, treat, and monitor cancers. Lead candidate iopofosine I 131 is in Phase 2/1 studies. Pipeline includes CLR 1900 cytotoxic compounds and collaborative PDC programs (CLR 2000, CLR 12120) with Avicenna and Orano Med, plus new PDCs with IntoCell and LegoChemBio.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellectar Biosciences company profile →
Qnovia
HQ: United States
Website
- Description: Provider of medtech and pharmaceutical drug-delivery solutions, including RespiRx, an inhalable prescription nicotine replacement therapy for smoking cessation; an inhaled drug delivery platform that optimizes and tracks dosing to improve efficacy and compliance; and a portable, orientation-agnostic vibrating mesh nebulizer with a digital metered dose interface, Bluetooth-enabled app, and a zero-maintenance disposable cartridge.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qnovia company profile →
IntelGenx
HQ: Canada
Website
- Description: Provider of oral drug delivery technologies focused on developing and manufacturing pharmaceutical oral films, transmucosal films, and transdermal patches. Solutions include VersaFilm and DisinteQ for rapidly dissolving oral films, VetaFilm for veterinary films for pets, Transmucosal Films for buccal/sublingual absorption, and VevaDerm for extended-release patches.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IntelGenx company profile →
BioNxt
HQ: Canada
Website
- Description: Provider of precision transdermal and oral drug formulations for neurological disorders; point-of-care diagnostics for infectious diseases (COVID-19, H1N1, H5N1), including a rapid COVID-19 PCR test; production, formulation, and validation of new APIs; industrial-scale production and clinical validation of psychedelic compounds for mental health treatments, including addiction and depression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioNxt company profile →
Nurse Assist
HQ: United States
Website
- Description: Provider of medical devices and USP sterile solutions, including prefilled saline syringes for IV flushing, sterile water and normal saline for irrigation and respiratory care, and sterile saline wound flush for moistening, debriding, and cleaning wounds, helping reduce contamination, medication errors, and needlestick injuries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nurse Assist company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TriSalus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TriSalus
2.2 - Growth funds investing in similar companies to TriSalus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TriSalus
4.2 - Public trading comparable groups for TriSalus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →